Stock A326030 SK BIOPHARMACEUTICALS CO., LTD.
Add to a list
To use this feature you must be a member
Log inSign up

Press Releases SK Biopharmaceuticals Co., Ltd.

Equities

A326030

KR7326030004

End-of-day quote Korea S.E.
Other stock markets
 23:00:00 27/06/2024 BST 		5-day change 1st Jan Change
77,500 KRW +2.38% Intraday chart for SK Biopharmaceuticals Co., Ltd. +1.97% -22.81%
05-10 SK Biopharmaceuticals Turns to Profit in Q1 as Sales Jump 88% MT
01-30 SK Biopharmaceuticals Swings to Profit in Q4 MT

Press Releases

Search
See the results
Unlock all the news on all businesses: Never miss an investment opportunity again!
100% Free Registration
SK Life Science - XCOPRI CV Receives FDA Approval for Alternate Methods of Administration That Include Crushed Tablet in Liquid Suspension Taken Orally or Through a Nasogastric Tube
AQ
SK Life Science Celebrates Purple Day Highlighting Partnerships and Tools Designed to Empower People Living with Epilepsy in Their Journey to Achieve Zero Seizures
AQ
Hikma and SK Biopharmaceuticals enter a strategic partnership for the Middle East and North Africa
AQ
SK to Showcase 40 Carbon Reduction Technologies at CES 2023
AQ
SK Biopharmaceuticals' Partner Angelini Pharma Launches Cenobamate in France
AQ
Seoul National University Bundang Hospital Presents
AQ
SK Biopharmaceuticals Named CES 2023 Innovation Awards Honoree
AQ
SK Biopharmaceuticals, Eurofarma Enter into Licensing Agreement for Cenobamate in Latin America
AQ
SK Biopharmaceuticals 2022 Sustainability Report Reinforces its commitment to ESG Management
AQ
SK Inc. - Biopharm Investment and Sister Company Sign Collaborations to Advance Promising Area of Drug Development
AQ
SK Biopharmaceuticals Becomes First Korean Company to Join PSCI
AQ
SK Biopharmaceuticals Reports 2021 Financial Results
AQ
Endo Announces Agreement for Paladin Labs to Commercialize SK Biopharmaceuticals' XCOPRI (Cenobamate) in Canada
AQ
SK Biopharmaceuticals : ONTOZRY (Cenobamate) receives European Commission approval
AQ
SK Biopharmaceuticals : to sell Arvelle Therapeutics stake to Angelini Pharma
AQ
Athira Pharma : SK Biopharmaceuticals and LifeSci Venture Partners Forge Ties for Open Innovation
AQ
SK Biopharmaceuticals : Ono Pharmaceutical Enter Licensing Agreement for Cenobamate in Japan
AQ
Ono Pharmaceutical : Enters into License Agreement on Cenobamate, an Antiepileptic Drug with SK Biopharmaceuticals
AQ
No results for this search
All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Search

Announcement Date

Since

Until

  1. Stock Market
  2. Equities
  3. A326030 Stock
  4. News SK Biopharmaceuticals Co., Ltd.
  5. Press Releases